Compounds > hoe 33342

hoe 33342 and Cancer of Prostate

hoe 33342 has been researched along with Cancer of Prostate in 12 studies

Research

Studies (12)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (16.67)	18.2507
2000's	9 (75.00)	29.6817
2010's	1 (8.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, FH; Chiang, CS; Fu, SY; Hong, JH; Wang, CC; Yang, YC	1
Chen, IJ; Liang, JC; Lin, HH; Liou, SF; Yeh, JL	1
Ma, J; Waxman, DJ	1
Godoy, A; Huss, WJ; Mathew, G; Montecinos, VP; Smith, GJ; Sotomayor, P; Timm, EA	1
Batra, SK; Mimeault, M	1
Campa, J; Carlin, S; Humm, JL; Larson, SM; Ling, CC; Pugachev, A; Ruan, S	1
Abderrahmani, A; Haefliger, JA; Leisinger, HJ; Martin, D; Tawadros, T; Waeber, G	1
Iijima, M; Ikeda, D; Kawada, M; Momose, I	1
Brown, MD; Clarke, NW; George, NJ; Gilmore, PE; Hart, CA; Ramani, VA; Samuel, JD	1
Joseph, PM; Lin, R; Livolsi, VA; Meyer, KL; Mukherji, B	1
Bolton, WE; Crumpler, DC; Jacobberger, JW; Sramkoski, RM; Wormsley, SW	1
Akao, Y; Banno, Y; Hattori, M; Hirabayasi, Y; Kito, M; Kusakabe, S; Nakagawa, Y; Nozawa, Y; Ohishi, N; Sawada, M; Tamiya-Koizumi, K	1

Other Studies

12 other study(ies) available for hoe 33342 and Cancer of Prostate

Article	Year
Combination of vessel-targeting agents and fractionated radiation therapy: the role of the SDF-1/CXCR4 pathway. International journal of radiation oncology, biology, physics, 2013, Jul-15, Volume: 86, Issue:4 Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Benzimidazoles; Benzylamines; Bone Marrow Cells; Chemokine CXCL12; Combined Modality Therapy; Cyclams; Dose Fractionation, Radiation; ErbB Receptors; Gefitinib; Green Fluorescent Proteins; Heterocyclic Compounds; Luminescent Agents; Male; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Pericytes; Prostatic Neoplasms; Quinazolines; Receptors, CXCR4; Tumor Microenvironment	2013
Inhibition of human prostate cancer cells proliferation by a selective alpha1-adrenoceptor antagonist labedipinedilol-A involves cell cycle arrest and apoptosis. Toxicology, 2009, Feb-04, Volume: 256, Issue:1-2 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Anisoles; Apoptosis; Benzimidazoles; Blotting, Western; Caspase 3; Caspase 9; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dihydropyridines; Fluorescent Dyes; Humans; Male; Membrane Potentials; Mitochondrial Membranes; Mitogen-Activated Protein Kinases; Oncogene Protein v-akt; Prostatic Neoplasms; Receptors, Adrenergic, alpha-1; Signal Transduction	2009
Dominant effect of antiangiogenesis in combination therapy involving cyclophosphamide and axitinib. Clinical cancer research : an official journal of the American Association for Cancer Research, 2009, Jan-15, Volume: 15, Issue:2 Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Axitinib; Benzimidazoles; Cell Line, Tumor; Cyclophosphamide; Genes, Dominant; Humans; Imidazoles; Indazoles; Male; Mice; Mice, Inbred ICR; Mice, SCID; Neoplasm Transplantation; Prostatic Neoplasms	2009
ABCG2-mediated DyeCycle Violet efflux defined side population in benign and malignant prostate. Cell cycle (Georgetown, Tex.), 2009, Apr-01, Volume: 8, Issue:7 Topics: Animals; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Benzimidazoles; Cell Line; Cell Line, Tumor; Cell Separation; DNA; Fluorescent Dyes; Humans; Indoles; Intercalating Agents; Male; Mice; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms	2009
Characterization of nonmalignant and malignant prostatic stem/progenitor cells by Hoechst side population method. Methods in molecular biology (Clifton, N.J.), 2009, Volume: 568 Topics: Benzimidazoles; Cell Culture Techniques; Cell Line, Tumor; Flow Cytometry; Humans; Male; Neoplastic Stem Cells; Prostate; Prostatic Neoplasms	2009
Dependence of FDG uptake on tumor microenvironment. International journal of radiation oncology, biology, physics, 2005, Jun-01, Volume: 62, Issue:2 Topics: Animals; Autoradiography; Benzimidazoles; Bromodeoxyuridine; Cell Hypoxia; Cell Proliferation; Coloring Agents; Fluorodeoxyglucose F18; Glucose; Male; Mice; Mice, Nude; Neoplasms; Nitroimidazoles; Prostatic Neoplasms; Radiopharmaceuticals	2005
IB1/JIP-1 controls JNK activation and increased during prostatic LNCaP cells neuroendocrine differentiation. Cellular signalling, 2005, Volume: 17, Issue:8 Topics: Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenoviridae; Animals; Apoptosis; Benzimidazoles; Blotting, Northern; Blotting, Western; Cell Differentiation; Cell Line, Tumor; Densitometry; Disease Progression; Enzyme Activation; Epithelial Cells; Fenretinide; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; JNK Mitogen-Activated Protein Kinases; Luciferases; Male; MAP Kinase Kinase 4; Microscopy, Fluorescence; Mitogen-Activated Protein Kinase Kinases; Neoplasms; Neurons; Neurosecretory Systems; Phenotype; Plasmids; Prostate; Prostatic Neoplasms; Rats; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA; Synaptophysin; Tetrazolium Salts; Thiazoles; Tissue Distribution; Transcription Factors; Transcription, Genetic; Up-Regulation	2005
A new proteasome inhibitor, TP-110, induces apoptosis in human prostate cancer PC-3 cells. Bioscience, biotechnology, and biochemistry, 2007, Volume: 71, Issue:4 Topics: Antibiotics, Antineoplastic; Apoptosis; Benzimidazoles; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Proliferation; DNA Fragmentation; Fluorescent Dyes; Humans; Male; NF-kappa B; Oligopeptides; Prostatic Neoplasms; Proteasome Inhibitors; Reverse Transcriptase Polymerase Chain Reaction	2007
Characterization of benign and malignant prostate epithelial Hoechst 33342 side populations. The Prostate, 2007, Sep-15, Volume: 67, Issue:13 Topics: AC133 Antigen; Adult Stem Cells; Antigens, CD; Benzimidazoles; Cell Fractionation; Cell Growth Processes; Cell Line; Epithelial Cells; Flow Cytometry; Fluorescent Dyes; Glycoproteins; Humans; Immunohistochemistry; Immunophenotyping; Leukocyte Common Antigens; Male; Microscopy, Confocal; Peptides; Prostatic Hyperplasia; Prostatic Neoplasms	2007
Measurement of vascular volume in experimental rat tumors by 19F magnetic resonance imaging. Investigative radiology, 1993, Volume: 28, Issue:8 Topics: Adenocarcinoma; Animals; Benzimidazoles; Blood Substitutes; Calibration; Fluorescent Dyes; Fluorine; Fluorocarbons; Magnetic Resonance Imaging; Male; Models, Structural; Neoplasm Transplantation; Prostatic Neoplasms; Rats; Tumor Cells, Cultured	1993
Simultaneous detection of cyclin B1, p105, and DNA content provides complete cell cycle phase fraction analysis of cells that endoreduplicate. Cytometry, 1999, Mar-01, Volume: 35, Issue:3 Topics: Benzimidazoles; Cell Cycle; Cell Line; Cell Separation; Cells, Immobilized; Cyclin B; Cyclin B1; DNA; Dose-Response Relationship, Drug; Flow Cytometry; Fluorescein; Fluorescein-5-isothiocyanate; Formaldehyde; Humans; Immunohistochemistry; Male; Methanol; Prostatic Neoplasms; Retinoblastoma Protein; Time Factors; Tumor Cells, Cultured	1999
Ceramide accumulation is independent of camptothecin-induced apoptosis in prostate cancer LNCaP cells. Biochemical and biophysical research communications, 2002, Jun-07, Volume: 294, Issue:2 Topics: Antineoplastic Agents; Apoptosis; Benzimidazoles; Camptothecin; Carboxylic Acids; Caspases; Ceramides; DNA Fragmentation; Enzyme Activation; Enzyme Inhibitors; Fumonisins; Humans; Male; Oxidoreductases; Prostatic Neoplasms; Sphingomyelin Phosphodiesterase; Sphingomyelins; Tumor Cells, Cultured	2002